Even more important than the development of a clinical trial Diversity Plan is the ability to move from intentions to actions in support of diversity, equity, and inclusion in clinical research. This panel discussion will share one company's approach to developing Diversity Plans, including actionable strategies that are being employed in a crossfunctional and collaborative manner.
CEU: 1.00 ACRP
Speakers:
A. Amanda Bishop, Associate Director, Clinical Trial Diversity Program Lead, Merck
Michelle Chawla, Diversity Program Lead, Merck
Cameron Davis, Associate Director, Clinical Trial Diversity, Merck
LaShanda Gordon, Associate Director, Diversity Program Lead, Merck
Watch a Sneak Peek into the Session Content: